Eli Lilly Reaches Global Axiron Testosterone Settlement
To settle hundreds of lawsuits over its testosterone replacement gel, Axiron, Eli Lilly agreed to a non-disclosed settlement amount. Men brought these claims from around the United States following heart attacks, blood clots, and other health problems after using the gel. About Axiron In 2010, the FDA approved Axiron, manufactured by pharmaceutical giant Eli Lilly. Within
Read More
AndroGel Trial Continues This Month
There are around 6,000 cases still pending against AbbVie for their testosterone product, AndroGel. Plaintiffs say AndroGel led to blood clots, heart attack, stroke and sudden death. Two trials have already ended both in jury verdicts against AbbVie totaling $290 million. About AndroGel The FDA approved testosterone products like AndroGel to treat hypogonadism. This illness is
Read More
Testosterone AndroGel User Receives $140M Verdict
A federal jury in Chicago found AbbVie Inc, the manufacturer of AndroGel fraudulently misrepresented the risks of its testosterone replacement drug. They ordered the company to pay the victim, Jeffery Konrad, $140 million in punitive damages. This is the second verdict against AbbVie from more than 6,000 similar lawsuits aimed at helping plaintiffs receive compensation for
Read MoreNew FDA Warning on Testosterone Products for Low T is a Game Changer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. The FDA just dramatically upped the stakes on the warnings on Low T treatments and the risk of cardiac events. The full FDA communication is below: Testosterone Products: Drug Safety Communication – FDA Cautions About Using Testosterone Products for Low Testosterone
Read More